Effects of Tiam 1 on Invasive Capacity of Gastric Cancer Cells in vitro and Underlying Mechanisms

  • Zhu, Jin-Ming (Department of General Surgery, Jinan Military General Hospital) ;
  • Yu, Pei-Wu (Department of General Surgery, Southwest Hospital, Third Military Medical University)
  • Published : 2013.01.31


Objective: To investigate changes in the invasive capacity of gastric cancer cells in vitro after expression inhibition of T lymphoma invasion and metastasis inducing factor 1 (Tiam 1) and underlying mechanisms. Methods: Using adhesion selection, two subpopulations with high ($M_H$) or low ($M_L$) invasive capacity were separated from the human gastric cancer cell line MKN-45 ($M_0$). Tiam 1 antisense oligodeoxynucleotide (ASODN) was transfected into $M_H$ cells with liposomes, and expression of Tiam 1 mRNA and protein was determined by RT-PCR and quantitative cellular-ELISA. Changes in the cytoskeleton, invasive capacity in vitro and expression of ras-related $C_3$ botulinum toxin substrate 1 (Rac 1), integrin ${\beta}1$ and matrix metalloproteinase 2 (MMP 2) between Tiam 1 ASODN transfected $M_H$ cells and non-transfected cells were observed by HE staining, cytoskeletal protein staining, scanning electron microscopy, Boyden chamber tests and cyto-immunohistochemistry. Results: A positive correlation existed between the expression level of Tiam l mRNA or protein and the invasion capacity of gastric cancer cells. After ASODN treatment ($0.43{\mu}M$ for 48 h), Tiam 1 mRNA transcription and protein expression in $M_H$ cells were decreased by 80% and 24% respectively (P < 0.05), compared with untreated controls, while invasive capacity in vitro was suppressed by 60% (P < 0.05). Morphologic and ultrastructural observation also showed that ASODN-treated $M_H$ cells exhibited smooth surfaces with obviously reduced filopodia and microspikes, which resembled $M_0$ and $M_L$ cells. Additionally, cytoskeletal distribution dramatically altered from disorder to regularity with reduced long filament-like structure, projections, pseudopodia on cell surface, and with decreased acitn-bodies in cytoplasm. After Tiam 1 ASODN treatment, the expression of Rac 1 and Integrin ${\beta}1$ in $M_H$ cells was not affected (P > 0.05), but that of MMP 2 in $M_H$ cells was significantly inhibited compared with untreated cells (P < 0.05). Conclusion: Over-expression of Tiam-1 contributes to the invasive phenotype of gastric cancer cells. Inhibition of Tiam 1 expression could impair the invasive capacity of gastric cancer cells through modulating reconstruction of the cytoskeleton and regulating expression of MMP 2.


  1. Habets GG, van der Kammen RA, Jenkins NA, et al (1995). The invasion-inducing TIAM1 gene maps to human chromosome band 21q22 and mouse chromosome 16. Cytogenet Cell Genet, 70, 48-51.
  2. Hamelers IH, Olivo C, Mertens AE, et al (2005). The Rac activator Tiam1 is required for (alpha)3(beta)1-mediated laminin-5 deposition, cell spreading, and cell migration. J Cell Biol, 171, 871-81.
  3. Hirohashi S, Kanai Y (2003). Cell adhesion system and human cancer morphogenesis. Cancer Sci, 94, 575-81.
  4. Huang J, Ye X, Guan J, et al (2013). Tiam1 is associated with hepatocellular carcinoma metastasis. Int J Cancer, 132, 90-100.
  5. Kim WH, Jun SH, Kibbey MC, et al (1994-1995). Expression of beta 1 integrin in laminin-adhesion-selected human colon cancer cell lines of varying tumorigenicity. Invasion Metastasis, 14, 147-55.
  6. Kim WH, Lee BL, Jun SH, et al (1998). Expression of 32/67-kDa laminin receptor in laminin adhesion-selected human colon cancer cell lines. Br J Cancer, 77, 15-20.
  7. Lee JH, Kim KM, Cheong JH, et al (2012). Current management and future strategies of gastric cancer. Yonsei Med J, 53, 248-57.
  8. Lin LL, Huang HC, Juan HF (2012). Discovery of biomarkers for gastric cancer: a proteomics approach. J Proteomics, 75, 3081-97.
  9. Li ZZ, Zhang L, Mao HF, et al (2000). Effect of Tiam-1 antisense oligodeoxynucleotides (ASODNS) on antimetastasis of tumor. Chin J Cancer Biother, 50, 767-77.
  10. Lleonart ME, Martin-Duque P, Sanchez-Prieto R, et al (2000). Tumor heterogeneity: morphological, molecular and clinical implications. Histol. Histopathol, 15, 881-98.
  11. Mahar AL, McLeod RS, Kiss A, et al (2012). A systematic review of the effect of institution and surgeon factors on surgical outcomes for gastric cancer. J Am Coll Surg, 214, 860-8.
  12. Malliri A, Collard JG (2003). Role of Rho-family proteins in cell adhesion and cancer. Curr Opin Cell Biol, 15, 583-9.
  13. Marhaba R, Zoller M (2004). CD44 in cancer progression: adhesion, migration and growth regulation. J Mol Histol, 35, 211-31.
  14. Mertens AE, Roovers RC, Collard JG (2003). Regulation of Tiam1-Rac signalling. FEBS Lett, 546, 11-6.
  15. Minard ME, Ellis LM, Gallick GE (2006). Tiam1 regulates cell adhesion, migration and apoptosis in colon tumor cells. Clin Exp Metastasis, 23, 301-13.
  16. Minard ME, Kim LS, Price JE, et al (2004). The role of the guanine nucleotide exchange factor Tiam1 in cellular migration, invasion, adhesion and tumor progression. Breast Cancer Res Treat, 84, 21-32.
  17. Okegawa T, Pong RC, Li Y, et al (2004). The role of cell adhesion molecule in cancer progression and its application in cancer therapy. Acta Biochim Pol, 51, 445-7.
  18. O'Toole TE, Bialkowska K, Li X, et al (2011). Tiam1 is recruited to $\beta 1$-integrin complexes by 14-3-$3\zeta$ where it mediates integrin-induced Rac1 activation and motility. J Cell Physiol, 226, 2965-78.
  19. Albini A, Iwamoto Y, Kleinman HK, et al (1987). A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res, 47, 3239-45.
  20. Ben-Ze'ev A (1985). The cytoskeleton in cancer cells. Biochim Biophys Acta, 780, 197-212.
  21. Chen B, Ding Y, Liu F, et al (2012). Tiam1, overexpressed in most malignancies, is a novel tumor biomarker. Mol Med Report, 5, 48-53.
  22. Chen X, Ren W, Dong J, et al (2001). Screening of gastric cancer cell sublines using the adhesion method. Chin J Digest Dis, 2, 121-4.
  23. Cruz-Monserrate Z, O'Connor KL (2008). Integrin alpha 6 beta 4 promotes migration, invasion through Tiam1 upregulation, and subsequent Rac activation. Neoplasia, 10, 408-17.
  24. Ekblom P, Lonai P, Talts JF (2003). Expression and biological role of laminin-1. Matrix Biol, 22, 35-47.
  25. Etienne MS, Hall A (2002). Rho GTPases in cell biology. Nature, 420, 629-35.
  26. Habets GG, Scholtes EH, Zuydgeest D, et al (1994). Identification of an invasion-inducing gene, Tiam-1, that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins. Cell, 77, 537-49.
  27. Wang HM, Wang J (2012). Expression of Tiam1 in lung cancer and its clinical significance. Asian Pac J Cancer Prev, 13, 613-5.
  28. Yokozaki H (2000). Molecular characteristics of eight gastric cancer cell lines established in Japan. Pathol Int, 50, 767-77.
  29. Zhang JH, Ding YQ, Yang XJ (1996). Introduction of a reforming staining method for cytoskeletal proteins. J Diag Pathol, 3, 235-6.
  30. Zhang X, Zhang R, Gu C, et al (2001). Expression level of ICAM-1 on cultured cells measured quantitatively with cellular ELISA. Acta Acad Med Mil Tert, 23, 117-8.
  31. Zhuge Y, Xu J (2001). Rac1 mediates type I collagen-dependent MMP-2 activation. role in cell invasion across collagen barrier. J Biol Chem, 276, 16248-56.
  32. Zhu JM, Yu PW, Zhao YL (2005). Relationship between the expression of Tiam 1, Rac 1 and the pathobiological behavior of gastric cancer. Chin J Gen Surg, 14, 168-72.

Cited by

  1. Prognostic Significance of α5β1-integrin Expression in Cervical Cancer vol.14, pp.6, 2013,
  2. Tiam1 siRNA enhanced the sensitivity of sorafenib on esophageal squamous cell carcinoma in vivo vol.35, pp.8, 2014,
  3. Adoptive Immunotherapy for Small Cell Lung Cancer by Expanded Activated Autologous Lymphocytes: a Retrospective Clinical Analysis vol.16, pp.4, 2015,
  4. Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast vol.16, pp.1, 2016,